Sedation with remazolam and remifentanil for sepsis patients
Treatments studied
Part of Infections clinical trials.
This study tests a combination of two sedative drugs (remazolam besylate and remifentanil) for calming patients with sepsis who are on a ventilator in the ICU. The goal is to see if this approach improves recovery compared to standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have sepsis and be on a breathing machine (ventilator) in the ICU.
- You must be expected to stay in the ICU for at least 2 days.
- You must be able to have light sedation (RASS score between -2 and 0).
- You or your family must agree to take part in the study (sign a consent form).
- You cannot be pregnant or breastfeeding.
- You cannot have severe liver disease or kidney failure needing dialysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medication called Remimazolam Besylate to sedate patients who need a breathing tube after heart surgery. The goal is to help patients relax while they recover in the intensive care unit.
This trial tests a sedative called remimazolam for people who are at higher risk during a painless bronchoscopy (a lung exam). It aims to see if this drug is safe and effective for you.
This study compares two sedative medicines, remimazolam and midazolam, for people who are on a ventilator and need deep sedation despite unstable blood pressure. The goal is to see which drug is safer and more effective for critically ill patients.
This study tests whether a sedative medication called remimazolam helps patients on breathing machines (ventilators) in the ICU recover better and have fewer complications. You would receive this medication to keep you calm and comfortable while on the ventilator.
This study compares two sedation medicines—remimazolam vs midazolam—for very sick ICU patients who are on a breathing machine. It looks at whether one sedative works better or is safer for keeping patients comfortable while they’re critically ill.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.